These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 20625277)
1. Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII. Ogiwara K; Nogami K; Nishiya K; Shima M Blood Coagul Fibrinolysis; 2010 Sep; 21(6):568-76. PubMed ID: 20625277 [TBL] [Abstract][Full Text] [Related]
2. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay. Kopitsky RG; Switzer ME; McKee PA Thromb Haemost; 1982 Apr; 47(2):145-9. PubMed ID: 6213066 [TBL] [Abstract][Full Text] [Related]
3. [Procoagulant properties of beta/gamma-thrombin]. Semenova OA; Strukova SM Vopr Med Khim; 1982; 28(4):137-40. PubMed ID: 6810543 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity. Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922 [TBL] [Abstract][Full Text] [Related]
5. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Nielsen VG; Cohen BM; Cohen E Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625 [TBL] [Abstract][Full Text] [Related]
6. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. van Veen JJ; Gatt A; Cooper PC; Kitchen S; Bowyer AE; Makris M Blood Coagul Fibrinolysis; 2008 Apr; 19(3):183-9. PubMed ID: 18388496 [TBL] [Abstract][Full Text] [Related]
7. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa. Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927 [TBL] [Abstract][Full Text] [Related]
8. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions. Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917 [TBL] [Abstract][Full Text] [Related]
9. Thrombin generation and phenotypic correlation in haemophilia A. Beltrán-Miranda CP; Khan A; Jaloma-Cruz AR; Laffan MA Haemophilia; 2005 Jul; 11(4):326-34. PubMed ID: 16011583 [TBL] [Abstract][Full Text] [Related]
10. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway. He R; Xiong S; He X; Liu F; Han J; Li J; He S Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684 [TBL] [Abstract][Full Text] [Related]
11. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]
12. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA; Cox LM; Bouma BN Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866 [TBL] [Abstract][Full Text] [Related]
13. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Matsumoto T; Nogami K; Shima M Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of TAK-442, a novel orally active direct factor Xa inhibitor, and ximelagatran, a thrombin inhibitor, on factor V-mediated feedback on coagulation cascade and bleeding. Konishi N; Hiroe K; Kawamura M Thromb Haemost; 2010 Sep; 104(3):504-13. PubMed ID: 20664909 [TBL] [Abstract][Full Text] [Related]
16. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Cardigan R; Philpot K; Cookson P; Luddington R Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989 [TBL] [Abstract][Full Text] [Related]
17. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor. Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059 [TBL] [Abstract][Full Text] [Related]
18. Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting. Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Sawamoto Y; Kamisue S; Fukui H Int J Hematol; 1991 Dec; 54(6):523-30. PubMed ID: 1724392 [TBL] [Abstract][Full Text] [Related]
19. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets. Chen YW; Chen JK; Wang JS Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321 [TBL] [Abstract][Full Text] [Related]
20. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model. Guimarães AH; Rijken DC Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]